Precision for Medicine - Senior Financial Analyst

• Europe: University degree in Accounting/Finance or related field or equivalent experience in accounting discipline • North America: Bachelor’s degree in Accounting/Finance or related business field • Five or more years general ledger and financial reporting experience including working knowledge of all areas of the accounting cycle, project budgets, financial project management support, Earned Value Analysis (“EVA”) analysis, and contract review or equivalent relevant experience and/or demonstrated competencies • Ability to undertake occasional domestic and international travel including overnight stays • Fluency in English and, in addition, for non-English speaking countries the local language of the country where position based • Certified Public Accountant (CPA) for North America or equivalent local qualification • CRO industry experience • Strong Working knowledge of the life cycle of a project with a solid foundation of how the financials and contract status impact each stage of the clinical trial • Working knowledge of accounts payable, accounts receivable, general ledger, bank reconciliations, QuickBooks or related software package, strong Excel /PC skills and able to thrive in multi-tasking environment • Strong accounting skills • High energy and enthusiasm with a strong commitment to exceeding expectations • Flexibility and willing to work on multiple assignments of varying tasks with personnel throughout the organization • Ability to learn quickly. Good oral and written communication & interpersonal skills with the ability to connect and build relationships with management and others throughout the organization • Exhibits self-motivation, and is able to work independently as well as in a team environment Team player with a desire to be an active, long-term participant in the growth of the company • Any data provided as a part of this application will be stored in accordance with our Privacy Policy. For CA applicants, please also refer to our CA Privacy Notice.